| Cancer | ID | Symbol | Immune Pathway | P value | FDR value | ES value | Score | number |
|---|---|---|---|---|---|---|---|---|
| ACC | ENSG00000179344 | HLA-DQB1 | Cytokine Receptors | 1.401e-03 | 3.948e-03 | 0.4212 | 0.9972 | 53 |
| ACC | ENSG00000179344 | HLA-DQB1 | Natural Killer Cell Cytotoxicity | 1.524e-03 | 3.948e-03 | 0.5725 | 0.997 | 25 |
| ACC | ENSG00000179344 | HLA-DQB1 | TCR signaling Pathway | 1.590e-03 | 3.948e-03 | 0.6131 | 0.9968 | 21 |
| ACC | ENSG00000198502 | HLA-DRB5 | Antigen Processing and Presentation | 1.370e-03 | 4.147e-03 | 0.5459 | 0.9973 | 36 |
| ACC | ENSG00000198502 | HLA-DRB5 | Antimicrobials | 1.170e-03 | 4.147e-03 | 0.4013 | 0.9977 | 92 |
| ACC | ENSG00000198502 | HLA-DRB5 | Chemokine Receptors | 1.555e-03 | 4.147e-03 | 0.6079 | 0.9969 | 13 |
| ACC | ENSG00000198502 | HLA-DRB5 | Cytokine Receptors | 1.253e-03 | 4.147e-03 | 0.4066 | 0.9975 | 49 |
| ACC | ENSG00000198502 | HLA-DRB5 | Natural Killer Cell Cytotoxicity | 1.370e-03 | 4.147e-03 | 0.5564 | 0.9973 | 30 |
| ACC | ENSG00000198502 | HLA-DRB5 | TCR signaling Pathway | 1.431e-03 | 4.147e-03 | 0.5718 | 0.9971 | 33 |
| ACC | ENSG00000075975 | MKRN2 | TCR signaling Pathway | 2.114e-03 | 3.383e-02 | 0.5379 | 0.9958 | 29 |
| ACC | ENSG00000157227 | MMP14 | Antigen Processing and Presentation | 1.821e-03 | 2.914e-02 | -0.4443 | -0.9964 | 36 |
| ACC | ENSG00000135679 | MDM2 | Natural Killer Cell Cytotoxicity | 1.992e-03 | 2.129e-02 | 0.4517 | 0.996 | 34 |
| ACC | ENSG00000152944 | MED21 | Antigen Processing and Presentation | 1.368e-03 | 2.189e-02 | 0.5093 | 0.9973 | 34 |